ES2052217T3 - Nuevos derivados de la piperidina, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen. - Google Patents
Nuevos derivados de la piperidina, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.Info
- Publication number
- ES2052217T3 ES2052217T3 ES90403537T ES90403537T ES2052217T3 ES 2052217 T3 ES2052217 T3 ES 2052217T3 ES 90403537 T ES90403537 T ES 90403537T ES 90403537 T ES90403537 T ES 90403537T ES 2052217 T3 ES2052217 T3 ES 2052217T3
- Authority
- ES
- Spain
- Prior art keywords
- image
- piperidine
- contain
- pathology
- preparation procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 239000005864 Sulphur Substances 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000003859 lipid peroxidation Effects 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 150000003053 piperidines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000006439 vascular pathology Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
NUEVOS DERIVADOS DE LA PIPERIDINA, UTILIZABLES COMO MEDICAMENTO Y QUE RESPONDEN A LA FORMULA: R-S N-R'' EN LA CUAL UNO DE LOS SUSTITUTOS R O R'' ES: (R10)M CH2 [M SIENDO 1,2 O 3 Y R SUB 1 =(C SUB 1 -C SUB 6)ALKILO] EL OTRO SUSTITUTO R O R'' ES O SEA: [A SIENDO UNA CADENA HIDROCARBONADA QUE CONTIENE EVENTUALMENTE UN DOBLE ENLACE, UN OXIGENO O UN AZUFRE, Y EVENTUALMENTE SUSTITUIDA POR OH O CH SUB 3 ], N SIENDO 1 O 2 R SUB 2, R'' SUB 2 Y R'''''' SUB 2 SIENDO HIDROGENO, HALOGENO (C SUB 1 -C SUB 5) ALKILO O ALKOLI O HIDROXI O SEA: Z SIENDO: OXIGENO O AZUFRE R": HIDROGENO O METILO P: CERO O UNO Y A, R SUB 2, R'' SUB 2, R" SUB 2 Y R'''''' SUB 2 TAL Y COMO SE DEFINEN MAS ARRIBA. ESTOS DERIVADOS Y SUS SALES FISIOLOGICAMENTE TOLERABLE PUEDEN SER UTILIZADOS EN TERAPEUTICA ESPECIALMENTE EN EL TRATAMIENTO DE LAS PATOLOGIAS LIGADAS CON LA ISQUEMIA TISULAR Y DE LA PATOLOGIA VASCULAR PERIFERICA, O EL TRATAMIENTO DE LAS PATOLOGIAS EN LAS CUALES UNA PEROXIDACION LIPIDICA DESEMPEÑA UN PAPEL INICIADOR Y/O AGRAVANTE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8916384A FR2655649B1 (fr) | 1989-12-12 | 1989-12-12 | Nouveaux derives de la piperidine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2052217T3 true ES2052217T3 (es) | 1994-07-01 |
Family
ID=9388394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES90403537T Expired - Lifetime ES2052217T3 (es) | 1989-12-12 | 1990-12-12 | Nuevos derivados de la piperidina, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5126356A (es) |
| EP (1) | EP0433167B1 (es) |
| JP (1) | JPH07100695B2 (es) |
| AT (1) | ATE102186T1 (es) |
| AU (1) | AU629076B2 (es) |
| CA (1) | CA2031839A1 (es) |
| DE (1) | DE69007045T2 (es) |
| DK (1) | DK0433167T3 (es) |
| ES (1) | ES2052217T3 (es) |
| FR (1) | FR2655649B1 (es) |
| IE (1) | IE66909B1 (es) |
| NZ (1) | NZ236231A (es) |
| OA (1) | OA09473A (es) |
| PT (1) | PT96156B (es) |
| ZA (1) | ZA909768B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU214331B (hu) * | 1992-06-17 | 1998-03-02 | Gyógyszerkutató Intézet Kft. | Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| AU2003235095A1 (en) * | 2002-05-28 | 2003-12-12 | Nippon Chemiphar Co., Ltd. | Piperidine derivatives |
| WO2005030721A1 (ja) * | 2003-09-30 | 2005-04-07 | Nippon Chemiphar Co., Ltd. | ピペリジン誘導体 |
| TWI759267B (zh) | 2015-07-02 | 2022-04-01 | 美商地平線罕見醫學製藥有限責任公司 | Ａｄｏ抗性半胱胺類似物及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB780027A (en) * | 1955-01-20 | 1957-07-31 | Schering Corp | 3-piperidyl ethers and thioethers |
| FR2514353A2 (fr) * | 1980-04-28 | 1983-04-15 | Synthelabo | Derives de piperidine et leur application en therapeutique |
| EP0077427B1 (fr) * | 1981-10-15 | 1985-05-22 | Synthelabo | Dérivés de pipéridine, leur procédé de préparation et leur application en thérapeutique |
| US4529730A (en) * | 1981-10-21 | 1985-07-16 | Synthelabo | Piperidine derivatives, their preparation and pharmaceutical compositions containing them |
| GB8321157D0 (en) * | 1983-08-05 | 1983-09-07 | Fordonal Sa | Piperidine derivatives |
| ZA848275B (en) * | 1983-12-28 | 1985-08-28 | Degussa | New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring |
-
1989
- 1989-12-12 FR FR8916384A patent/FR2655649B1/fr not_active Expired - Fee Related
-
1990
- 1990-11-27 NZ NZ236231A patent/NZ236231A/en unknown
- 1990-12-05 ZA ZA909768A patent/ZA909768B/xx unknown
- 1990-12-07 CA CA002031839A patent/CA2031839A1/fr not_active Abandoned
- 1990-12-10 IE IE443490A patent/IE66909B1/en not_active IP Right Cessation
- 1990-12-11 AU AU67936/90A patent/AU629076B2/en not_active Ceased
- 1990-12-11 PT PT96156A patent/PT96156B/pt not_active IP Right Cessation
- 1990-12-11 US US07/625,422 patent/US5126356A/en not_active Expired - Fee Related
- 1990-12-12 ES ES90403537T patent/ES2052217T3/es not_active Expired - Lifetime
- 1990-12-12 OA OA59915A patent/OA09473A/xx unknown
- 1990-12-12 EP EP90403537A patent/EP0433167B1/fr not_active Expired - Lifetime
- 1990-12-12 JP JP2419227A patent/JPH07100695B2/ja not_active Expired - Lifetime
- 1990-12-12 DE DE69007045T patent/DE69007045T2/de not_active Expired - Fee Related
- 1990-12-12 DK DK90403537.5T patent/DK0433167T3/da active
- 1990-12-12 AT AT90403537T patent/ATE102186T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69007045T2 (de) | 1994-08-04 |
| FR2655649A1 (fr) | 1991-06-14 |
| OA09473A (fr) | 1992-11-15 |
| IE66909B1 (en) | 1996-02-07 |
| US5126356A (en) | 1992-06-30 |
| IE904434A1 (en) | 1991-06-19 |
| JPH06340626A (ja) | 1994-12-13 |
| ATE102186T1 (de) | 1994-03-15 |
| FR2655649B1 (fr) | 1994-07-08 |
| CA2031839A1 (fr) | 1991-06-13 |
| AU629076B2 (en) | 1992-09-24 |
| EP0433167A1 (fr) | 1991-06-19 |
| ZA909768B (en) | 1991-09-25 |
| AU6793690A (en) | 1991-06-20 |
| NZ236231A (en) | 1992-07-28 |
| JPH07100695B2 (ja) | 1995-11-01 |
| DK0433167T3 (da) | 1994-05-02 |
| PT96156A (pt) | 1991-09-30 |
| EP0433167B1 (fr) | 1994-03-02 |
| DE69007045D1 (de) | 1994-04-07 |
| PT96156B (pt) | 1998-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE40368T1 (de) | Xanthin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE10741T1 (de) | Dibenzo(b,f)(1,4)oxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| KR910006235A (ko) | 치환된 이소퀴놀린 및 이것의 사용방법 | |
| KR870007118A (ko) | 광학적으로 순수한 화합물 및 그의 제조 방법 | |
| ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
| KR900016098A (ko) | 카페인산의 유도체 및 이를 함유하는 약제학적 조성물 | |
| ATE6645T1 (de) | Dibenzoxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ES2052217T3 (es) | Nuevos derivados de la piperidina, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen. | |
| ES2069719T3 (es) | Nuevos derivados de tiofeno, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2072118T3 (es) | Nuevos derivados de benzoato de etanolamina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| KR900014397A (ko) | 티에노-트리아졸로-디아제핀 술포닐 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물 | |
| ES2077473T3 (es) | Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| PT90813A (pt) | Processo de preparacao de derivados da fenotiazina e de composicoes farmaceuticas que os contem | |
| ATE37368T1 (de) | Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DK601888A (da) | Anvendelse af 2-pyrimidinyl-1-piperazinderivater | |
| ATE68178T1 (de) | 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ATE1066T1 (de) | Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahy dro-1h-1-benzazepin-2-ons, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| ATE28871T1 (de) | Disubstituierte piperidine,verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| FI820749L (fi) | Benso (4,5) pyrano (2,3c) pyrroler foerfaranden foer deras framstaellning och dessa innehaollande farmaceutiska produkter | |
| FI894068A0 (fi) | Sulfonamider med tetrazolylrest, foerfarande foer deras tillverkning och laekemedel. | |
| ATE7224T1 (de) | Propanolamin-derivate, ihre salze, verfahren zu ihrer herstellung und pharmazeutische praeparate. | |
| SE8004351L (sv) | (3-alkylamino-2-hydroxipropoxi)-furan-2-karbonsyra-anilider och fysiologiskt fordragbara syraadditionssalter derav samt lekemedel med en halt av dessa foreningar | |
| SE8400629L (sv) | Basiska oximetrar | |
| PT93904A (pt) | Processo para a preparacao de novos derivados benzotiazolinonicos e de composicoes farmaceuticas que os contem | |
| PT97885A (pt) | Processo para a preparacao de derivados da {(1-aril-2-pirrolidinil)-metil-piperazina e de composicoes farmaceuticas que os contem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 433167 Country of ref document: ES |